Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
About Investor
Brett Zbar serves as the Managing Director and Global Head of Life Sciences at General Atlantic, concentrating on investments in Consumer Health, BioTech, Health & Hospital Services, Health IT, and Digital Health sectors. He typically invests at Seed through Series B stages with investment ranges between $100K and $5.0M. Based in New York City with operations in the San Francisco Bay Area, Zbar has established himself as a prominent investor in the life sciences and healthcare technology sectors.
Previous investments
Verdiva Bio
410M |2025
Seaport Therapeutics
230M |2024
Pharvaris
80M |2020
66M |2019
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.